December 23, 2024

Signs of Dementia Are Written in the Blood: 33 Metabolic Compounds May Be Key to New Treatments

By Okinawa Institute of Science and Technology Graduate University
November 1, 2021

33 metabolic compounds linked to dementia could be key to brand-new techniques of medical diagnosis and treatment.

A heat-map, where red shows high levels of a compound, and blue shows low levels of a substance, exposes the link in between certain metabolites and dementia. Compounds in sub-group A were usually greater in dementia patients and lower in healthy senior people. The researchers measured the levels of 124 different metabolites in entire blood and discovered that 33 metabolites, divided into 5 different sub-groups, correlated with dementia. Seven of these substances increased in dementia patients, whilst 26 of these compounds showed a decline in levels. 20, consisting of 9 that were abundant in red blood cells, of these substances had actually not previously been connected to dementia.

Scientists in Japan have actually determined metabolic substances within the blood that are related to dementia.

The research study revealed that the levels of 33 metabolites differed in clients with dementia, compared to senior people with no existing health conditions. Their findings, published just recently in PNAS, might one day help diagnosis and treatment of dementia.
” Metabolites are chemical substances produced by vital chemical reactions that take place within tissues and cells,” stated first author Dr. Takayuki Teruya, who works in the G0 Cell Unit at the Okinawa Institute of Science and Technology Graduate University (OIST). “Our body generally keeps these levels in balance, however as we age and if we develop diseases like dementia, these levels can change and change.”
Dementia is not simply a single illness, but a general term used to explain a set of symptoms, including a sluggish but generally irreparable decrease in the capability to remember, think, make decisions or perform everyday activities. Of all aging-associated diseases, dementia is among the most severe, not only for the clients and their family but for society as a whole, with an estimated 55 million people dealing with the illness worldwide.
A heat-map, where red programs high levels of a compound, and blue shows low levels of a substance, reveals the link between certain metabolites and dementia. Compounds in sub-group A were normally higher in dementia clients and lower in healthy senior people. Compounds in sub-group B-E revealed the opposite impact. Credit: OIST
While scientists understand that dementia is triggered by damage to nerves, the precise cause of this damage, and methods as to how it can be detected and treated have stayed elusive.
In the study, the research study group examined samples of blood gathered from eight clients with dementia, as well as 8 healthy senior individuals. They likewise gathered samples from eight healthy youths to use as a recommendation. Unlike most studies analyzing blood metabolites, this research consisted of compounds discovered within red cell.
” Blood cells are difficult to deal with since they go through metabolic modifications if left untreated even for a brief time period,” explained Dr. Teruya.
Nevertheless, the research study group recently developed a method to support metabolites in red blood cells, enabling them to analyze for the very first time the relationship between red blood cell activity and dementia.
The researchers measured the levels of 124 various metabolites in entire blood and discovered that 33 metabolites, split into 5 various sub-groups, associated with dementia. Seven of these compounds increased in dementia patients, whilst 26 of these compounds revealed a decrease in levels. 20, consisting of nine that were abundant in red cell, of these compounds had not previously been linked to dementia.
” Identification of these substances means that we are one step closer to being able to molecularly diagnose dementia,” stated senior author of the study, Professor Mitsuhiro Yanagida, who leads the G0 Cell Unit at OIST.
The seven metabolites that showed increased levels in clients with dementia were discovered within the blood plasma and came from sub-group A of metabolites. Importantly, a few of these compounds are thought to have poisonous impacts on the main nerve system.
” Its still too early to say, however it might recommend a possible mechanistic reason for dementia as these substances may cause impairment of the brain,” stated Prof. Yanagida.
The research team prepares to test this concept in the next steps of their research study, by seeing if increases in these metabolites can cause dementia in animal models, like mice.
The staying 26 substances that decreased in patients with dementia, compared to healthy elderly individuals, belonged to 4 other metabolite sub-groups, B-E.
6 metabolites that reduced in dementia patients were categorized into sub-group B, due to their comparable structure. These metabolic compounds are anti-oxidants, which protect cells and tissues by minimizing damage caused by complimentary radicals– unsteady molecules produced by chemical reactions in cells. The scientists discovered that these antioxidant compounds originated from food were highly abundant in red blood cells of healthy elderly individuals.
” It might be that red cell deliver not just oxygen however likewise important metabolites that safeguard the nerve system from damage,” said Dr. Teruya.
The staying sub-groups consist of substances that the researchers think play a function in supplying nutrients, maintaining energy reserves and securing nerve cells from damage.
” In the future, we intend to start some intervention studies, either by supplementing dementia clients with metabolic substances in sub-groups B-E, or by preventing the neurotoxins from sub-group A, to see if that can slow, prevent, and even reverse symptoms of dementia,” said Prof. Yanagida.
Recommendation: “Whole-blood metabolomics of dementia clients reveal classes of disease-linked metabolites” by Takayuki Teruya, Yung-Ju Chen, Hiroshi Kondoh, Yasuhide Fukuji and Mitsuhiro Yanagida, 7 September 2021, Proceedings of the National Academy of Sciences.DOI: 10.1073/ pnas.2022857118.
The research study was performed by the Okinawa Institute of Science and Technology Graduate University, together with the National Ryukyu Hospital, Okinawa and Kyoto University.

Scientists have identified 33 metabolic substances that are connected to dementia
7 metabolites were discovered at higher levels in patients with dementia, compared to healthy senior individuals
These metabolites are thought to be poisonous to neurons and could mean a possible cause for dementia
26 metabolites were found at lower levels in clients with dementia, compared to elderly individuals with no health conditions
These metabolites are thought to safeguard neurons against damage from complimentary radicals, assistance maintain energy reserves and provide nutrition
Supplements that raise the levels of these metabolites could be a prospective brand-new treatment for dementia